The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Rapid Influenza Diagnostic Test (RIDT) Market Research Report 2024

Global Rapid Influenza Diagnostic Test (RIDT) Market Research Report 2024

Publishing Date : Jan, 2024

License Type :
 

Report Code : 1426327

No of Pages : 99

Synopsis
Rapid influenza diagnostic tests (RIDTs) are immunoassays that can identify the presence of influenza A and B viral nucleoprotein antigens in respiratory specimens, and display the result in a qualitative way (positive vs. negative). In the United States, a number of RIDTs are commercially available. The reference standards for laboratory confirmation of influenza virus infection in respiratory specimens are reverse transcription-polymerase chain reaction (RT-PCR) or viral culture. RIDTs can yield results in a clinically relevant time frame, i.e., less than approximately 15 minutes. However, RIDTs have limited sensitivity to detect influenza viruses in respiratory specimens compared to RT-PCR or viral culture and negative RIDT test results should be interpreted with caution given the potential for false negative results, especially during peak influenza activity in a community. Some RIDTs use analyzer reader devices to standardize result interpretation.
The global Rapid Influenza Diagnostic Test (RIDT) market was valued at US$ 1269.1 million in 2023 and is anticipated to reach US$ 2336.3 million by 2030, witnessing a CAGR of 9.0% during the forecast period 2024-2030.
Americas is the largest Rapid Influenza Diagnostic Test (RIDT) market with about 58% market share. Europe is follower, accounting for about 25% market share.
The key players are BD, Abbot (Alere), Quidel, Roche, Thermo Fisher Scientific, Meridian Bioscience, Analytik Jena, Princeton BioMeditech Corporation, BioMerieux, Sekisui Diagnostics, Response Biomedical, SA Scientific, DiaSorin (Focus Diagnostics), Wondfo, Beijing Wantai Biological Pharmacy etc. Top 3 companies occupied about 49% market share.
This report aims to provide a comprehensive presentation of the global market for Rapid Influenza Diagnostic Test (RIDT), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rapid Influenza Diagnostic Test (RIDT).
Report Scope
The Rapid Influenza Diagnostic Test (RIDT) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Rapid Influenza Diagnostic Test (RIDT) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Rapid Influenza Diagnostic Test (RIDT) companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
BD
Abbot (Alere)
Quidel
Roche
Thermo Fisher Scientific
Meridian Bioscience
Analytik Jena
Princeton BioMeditech Corporation
BioMerieux
Sekisui Diagnostics
Response Biomedical
SA Scientific
DiaSorin (Focus Diagnostics)
Wondfo
Beijing Wantai Biological Pharmacy
Segment by Type
Digital RIDTs
Conventional RIDT
Segment by Application
Hospitals
POCT
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Rapid Influenza Diagnostic Test (RIDT) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Rapid Influenza Diagnostic Test (RIDT) Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Digital RIDTs
1.2.3 Conventional RIDT
1.3 Market by Application
1.3.1 Global Rapid Influenza Diagnostic Test (RIDT) Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 POCT
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Rapid Influenza Diagnostic Test (RIDT) Market Perspective (2019-2030)
2.2 Rapid Influenza Diagnostic Test (RIDT) Growth Trends by Region
2.2.1 Global Rapid Influenza Diagnostic Test (RIDT) Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Rapid Influenza Diagnostic Test (RIDT) Historic Market Size by Region (2019-2024)
2.2.3 Rapid Influenza Diagnostic Test (RIDT) Forecasted Market Size by Region (2025-2030)
2.3 Rapid Influenza Diagnostic Test (RIDT) Market Dynamics
2.3.1 Rapid Influenza Diagnostic Test (RIDT) Industry Trends
2.3.2 Rapid Influenza Diagnostic Test (RIDT) Market Drivers
2.3.3 Rapid Influenza Diagnostic Test (RIDT) Market Challenges
2.3.4 Rapid Influenza Diagnostic Test (RIDT) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Rapid Influenza Diagnostic Test (RIDT) Players by Revenue
3.1.1 Global Top Rapid Influenza Diagnostic Test (RIDT) Players by Revenue (2019-2024)
3.1.2 Global Rapid Influenza Diagnostic Test (RIDT) Revenue Market Share by Players (2019-2024)
3.2 Global Rapid Influenza Diagnostic Test (RIDT) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Rapid Influenza Diagnostic Test (RIDT) Revenue
3.4 Global Rapid Influenza Diagnostic Test (RIDT) Market Concentration Ratio
3.4.1 Global Rapid Influenza Diagnostic Test (RIDT) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Rapid Influenza Diagnostic Test (RIDT) Revenue in 2023
3.5 Rapid Influenza Diagnostic Test (RIDT) Key Players Head office and Area Served
3.6 Key Players Rapid Influenza Diagnostic Test (RIDT) Product Solution and Service
3.7 Date of Enter into Rapid Influenza Diagnostic Test (RIDT) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Rapid Influenza Diagnostic Test (RIDT) Breakdown Data by Type
4.1 Global Rapid Influenza Diagnostic Test (RIDT) Historic Market Size by Type (2019-2024)
4.2 Global Rapid Influenza Diagnostic Test (RIDT) Forecasted Market Size by Type (2025-2030)
5 Rapid Influenza Diagnostic Test (RIDT) Breakdown Data by Application
5.1 Global Rapid Influenza Diagnostic Test (RIDT) Historic Market Size by Application (2019-2024)
5.2 Global Rapid Influenza Diagnostic Test (RIDT) Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Rapid Influenza Diagnostic Test (RIDT) Market Size (2019-2030)
6.2 North America Rapid Influenza Diagnostic Test (RIDT) Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Rapid Influenza Diagnostic Test (RIDT) Market Size by Country (2019-2024)
6.4 North America Rapid Influenza Diagnostic Test (RIDT) Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Rapid Influenza Diagnostic Test (RIDT) Market Size (2019-2030)
7.2 Europe Rapid Influenza Diagnostic Test (RIDT) Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Rapid Influenza Diagnostic Test (RIDT) Market Size by Country (2019-2024)
7.4 Europe Rapid Influenza Diagnostic Test (RIDT) Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Rapid Influenza Diagnostic Test (RIDT) Market Size (2019-2030)
8.2 Asia-Pacific Rapid Influenza Diagnostic Test (RIDT) Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Rapid Influenza Diagnostic Test (RIDT) Market Size by Region (2019-2024)
8.4 Asia-Pacific Rapid Influenza Diagnostic Test (RIDT) Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Rapid Influenza Diagnostic Test (RIDT) Market Size (2019-2030)
9.2 Latin America Rapid Influenza Diagnostic Test (RIDT) Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Rapid Influenza Diagnostic Test (RIDT) Market Size by Country (2019-2024)
9.4 Latin America Rapid Influenza Diagnostic Test (RIDT) Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Rapid Influenza Diagnostic Test (RIDT) Market Size (2019-2030)
10.2 Middle East & Africa Rapid Influenza Diagnostic Test (RIDT) Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Rapid Influenza Diagnostic Test (RIDT) Market Size by Country (2019-2024)
10.4 Middle East & Africa Rapid Influenza Diagnostic Test (RIDT) Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 BD
11.1.1 BD Company Detail
11.1.2 BD Business Overview
11.1.3 BD Rapid Influenza Diagnostic Test (RIDT) Introduction
11.1.4 BD Revenue in Rapid Influenza Diagnostic Test (RIDT) Business (2019-2024)
11.1.5 BD Recent Development
11.2 Abbot (Alere)
11.2.1 Abbot (Alere) Company Detail
11.2.2 Abbot (Alere) Business Overview
11.2.3 Abbot (Alere) Rapid Influenza Diagnostic Test (RIDT) Introduction
11.2.4 Abbot (Alere) Revenue in Rapid Influenza Diagnostic Test (RIDT) Business (2019-2024)
11.2.5 Abbot (Alere) Recent Development
11.3 Quidel
11.3.1 Quidel Company Detail
11.3.2 Quidel Business Overview
11.3.3 Quidel Rapid Influenza Diagnostic Test (RIDT) Introduction
11.3.4 Quidel Revenue in Rapid Influenza Diagnostic Test (RIDT) Business (2019-2024)
11.3.5 Quidel Recent Development
11.4 Roche
11.4.1 Roche Company Detail
11.4.2 Roche Business Overview
11.4.3 Roche Rapid Influenza Diagnostic Test (RIDT) Introduction
11.4.4 Roche Revenue in Rapid Influenza Diagnostic Test (RIDT) Business (2019-2024)
11.4.5 Roche Recent Development
11.5 Thermo Fisher Scientific
11.5.1 Thermo Fisher Scientific Company Detail
11.5.2 Thermo Fisher Scientific Business Overview
11.5.3 Thermo Fisher Scientific Rapid Influenza Diagnostic Test (RIDT) Introduction
11.5.4 Thermo Fisher Scientific Revenue in Rapid Influenza Diagnostic Test (RIDT) Business (2019-2024)
11.5.5 Thermo Fisher Scientific Recent Development
11.6 Meridian Bioscience
11.6.1 Meridian Bioscience Company Detail
11.6.2 Meridian Bioscience Business Overview
11.6.3 Meridian Bioscience Rapid Influenza Diagnostic Test (RIDT) Introduction
11.6.4 Meridian Bioscience Revenue in Rapid Influenza Diagnostic Test (RIDT) Business (2019-2024)
11.6.5 Meridian Bioscience Recent Development
11.7 Analytik Jena
11.7.1 Analytik Jena Company Detail
11.7.2 Analytik Jena Business Overview
11.7.3 Analytik Jena Rapid Influenza Diagnostic Test (RIDT) Introduction
11.7.4 Analytik Jena Revenue in Rapid Influenza Diagnostic Test (RIDT) Business (2019-2024)
11.7.5 Analytik Jena Recent Development
11.8 Princeton BioMeditech Corporation
11.8.1 Princeton BioMeditech Corporation Company Detail
11.8.2 Princeton BioMeditech Corporation Business Overview
11.8.3 Princeton BioMeditech Corporation Rapid Influenza Diagnostic Test (RIDT) Introduction
11.8.4 Princeton BioMeditech Corporation Revenue in Rapid Influenza Diagnostic Test (RIDT) Business (2019-2024)
11.8.5 Princeton BioMeditech Corporation Recent Development
11.9 BioMerieux
11.9.1 BioMerieux Company Detail
11.9.2 BioMerieux Business Overview
11.9.3 BioMerieux Rapid Influenza Diagnostic Test (RIDT) Introduction
11.9.4 BioMerieux Revenue in Rapid Influenza Diagnostic Test (RIDT) Business (2019-2024)
11.9.5 BioMerieux Recent Development
11.10 Sekisui Diagnostics
11.10.1 Sekisui Diagnostics Company Detail
11.10.2 Sekisui Diagnostics Business Overview
11.10.3 Sekisui Diagnostics Rapid Influenza Diagnostic Test (RIDT) Introduction
11.10.4 Sekisui Diagnostics Revenue in Rapid Influenza Diagnostic Test (RIDT) Business (2019-2024)
11.10.5 Sekisui Diagnostics Recent Development
11.11 Response Biomedical
11.11.1 Response Biomedical Company Detail
11.11.2 Response Biomedical Business Overview
11.11.3 Response Biomedical Rapid Influenza Diagnostic Test (RIDT) Introduction
11.11.4 Response Biomedical Revenue in Rapid Influenza Diagnostic Test (RIDT) Business (2019-2024)
11.11.5 Response Biomedical Recent Development
11.12 SA Scientific
11.12.1 SA Scientific Company Detail
11.12.2 SA Scientific Business Overview
11.12.3 SA Scientific Rapid Influenza Diagnostic Test (RIDT) Introduction
11.12.4 SA Scientific Revenue in Rapid Influenza Diagnostic Test (RIDT) Business (2019-2024)
11.12.5 SA Scientific Recent Development
11.13 DiaSorin (Focus Diagnostics)
11.13.1 DiaSorin (Focus Diagnostics) Company Detail
11.13.2 DiaSorin (Focus Diagnostics) Business Overview
11.13.3 DiaSorin (Focus Diagnostics) Rapid Influenza Diagnostic Test (RIDT) Introduction
11.13.4 DiaSorin (Focus Diagnostics) Revenue in Rapid Influenza Diagnostic Test (RIDT) Business (2019-2024)
11.13.5 DiaSorin (Focus Diagnostics) Recent Development
11.14 Wondfo
11.14.1 Wondfo Company Detail
11.14.2 Wondfo Business Overview
11.14.3 Wondfo Rapid Influenza Diagnostic Test (RIDT) Introduction
11.14.4 Wondfo Revenue in Rapid Influenza Diagnostic Test (RIDT) Business (2019-2024)
11.14.5 Wondfo Recent Development
11.15 Beijing Wantai Biological Pharmacy
11.15.1 Beijing Wantai Biological Pharmacy Company Detail
11.15.2 Beijing Wantai Biological Pharmacy Business Overview
11.15.3 Beijing Wantai Biological Pharmacy Rapid Influenza Diagnostic Test (RIDT) Introduction
11.15.4 Beijing Wantai Biological Pharmacy Revenue in Rapid Influenza Diagnostic Test (RIDT) Business (2019-2024)
11.15.5 Beijing Wantai Biological Pharmacy Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’